Dr. GSK Velu, Chairman & MD - Trivitron Healthcare. Request you to please disseminate it to relevant media in your centers. ''Budget 2020 is visionary and in accordance with the policy of improving and expanding healthcare services reach to all. Make in India initiative for Medical devices industry has been given a big boost. Imposing health cess on the import of medical devices will help domestic manufacturing companies. Further, using tax proceeds to fund the creation of healthcare infrastructure will help in address issues of capital requirements for building healthcare infra in Tier- I & II cities. The government is focused on creating the healthcare infrastructure and invest extensively in improving healthcare services in tier I-II cities in the country. Announcement of extending the ambit of Ayushman Bharat through the establishment of PPP model hospitals in 112 new districts of India will improve healthcare infrastructure. Increasing the budgetary allocation for the healthcare sector to 69,000 crores will enhance primary health coverage and strengthen health and wellness centers (announced under Ayushman Bharat) which will help to reduce the disease burden.'' Dr. GSK Velu, Chairman & MD - Trivitron Healthcare.

Dr. GSK Velu, Chairman & MD - Trivitron Healthcare

''Budget 2020 is visionary and in accordance with the policy of improving and expanding healthcare services reach to all. Make in India initiative for Medical devices industry has been given a big boost. Imposing health acess on the import of medical devices will help domestic manufacturing companies.

Further, using tax proceeds to fund the creation of healthcare infrastructure will help in address issues of capital requirements for building healthcare infra in Tier- I & II cities.

The government is focused on creating the healthcare infrastructure and invest extensively in improving healthcare services in tier I-II cities in the country. Announcement of extending the ambit of Ayushman Bharat through the establishment of PPP model hospitals in 112 new districts of India will improve healthcare infrastructure.  

Increasing the budgetary allocation for the healthcare sector to 69,000 crores will enhance primary health coverage and strengthen health and wellness centers (announced under Ayushman Bharat) which will help to reduce the disease burden.''  

Dr. GSK Velu, Chairman & MD - Trivitron Healthcare.  

4th International Conference on Pharma& Medical Devices

Call for separate regulations for medical devices and OTC drugs

4^th International Conference on Pharma& Medical Devices concludes

·         Thrust on data revolution in the pharmaceutical and medical device sector through AI

·         Mega event concludes with 500+ Indian and International trade visitors,  CEOs’ participation and 250+ academicians and students

The 4th International Conference on Pharmaceuticals and Medical Devices which concluded witnessed the participation of drug regulators from over 30 countries including Russia, Kenya, the UK, Malaysia, Indonesia, Saudi Arabia and Uzbekistan, along with participation of Indian drug regulators from 15 states.

The conference was organised by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers and Government of India jointly with the Federation of Indian Chambers of Commerce & Industry (FICCI).

Some of the issues discussed at the CEOs roundtable included development of separate medical device and over-the-counter (OTC) drug regulations act, early decision on implementation of trade margin rationalization, addressing the issue of Active Pharmaceutical Ingredients (APIs) price escalation imported from China,  incentivisation for innovation in the pharmaceutical and medical device sector, greater transparency in the functioning of National Pharmaceutical Pricing Authority (NPPA) and last but not the least, amendments by the Ministry of Consumer Affairs for allowing companies to utilise the mandatory CSR spending towards medicine donations into Jan Aushadhi or Ayushman Bharat scheme.

Knowledge sessions were focused towards promoting innovative ecosystem in India for pharmaceutical industry, interaction with State Drug Controllers and CDSCO for facilitating ease of doing business, initiatives for import registration procedure to enable faster access to global market for the industry, WHO activities and plans related to the regulation of health technologies and enabling the industry to gear up for Ayushman Bharat, the most aspirational health scheme rolled out by the government.

In his concluding remarks, Mr.  NavdeepRinwa, Joint Secretary, Department of Pharmaceutical, Government of India, mentioned how the government was prioritising the pharma and medical device sector in AI applications by bringing in task forces and other policies in place.